Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ionis Pharmaceuticals, Inc.
With
Akcea Therapeutics
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Must have given written informed consent and be able to comply with all study requirements
Males and females aged 18-55 at the time of informed consent
Females must be non-pregnant and non-lactating surgically sterile, post-menopausal or if engaged in sexual relations of childbearing potential, using an acceptable contraceptive method
Males must be surgically sterile, abstinent or using an acceptable contraceptive method
The subject has a BMI of 19 to 32 kg/m\^2 inclusive
Consumption of nicotine or nicotine-containing products for at least 6 months before Screening
You may not be if
History of risk factors for Torsades de Pointes, unexplained syncope, known Long QT Syndrome, heart failure, myocardial infarction, angina, or clinical significant abnormal laboratory assessments including hypokalemia, hypocalcemia, hypercalcemia, or hypomagnesemia
Abnormal screening ECG
Use of concomitant medications unless authorized by the Sponsor Medical Monitor
Known history of or positive test for human immunodeficiency virus (HIV), hepatitis C or chronic hepatitis B
Treatment with another Study Drug, biological agent, or device within one-month of Screening
Tests positive for drugs of abuse or cotinine
Considered unsuitable for inclusion by the Principal Investigator
